Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics announces Plasmid DNA Manufacturing: An Optimized Platform Process Webinar
14 juin 2021 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, June 14, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene therapy...
ARC logo.png
Handheld DNA Analyzer Market Is Projected To Witness The Fastest Growth In Asia-Pacific Region During Forthcoming Years 2020-2027: Acumen Research And Consulting
10 mars 2021 14h46 HE | Acumen Research and Consulting
LOS ANGELES, March 10, 2021 (GLOBE NEWSWIRE) -- Many companies are accelerating the R&D activities to sequence DNA faster and cheaper. The Handheld DNA Analyzer device was developed by the...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing
08 mars 2021 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
22157.jpg
Global Viral Vector & Plasmid DNA Manufacturing Market Report 2021 - Rising Use of Viral Vectors in Several Treatments Demands Developments in Plasmids and Vectors
17 févr. 2021 05h48 HE | Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Workflow, by Application, by End User - Global Forecast to 2025 -...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics announces Regulatory Strategies for Gene Therapy Product Development webinar
08 févr. 2021 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, Okla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene...
22157.jpg
Global Viral Vector and Plasmid DNA Manufacturing Market Trends & Forecasts Report 2020-2025: Explore the Potential Applications in Novel Drug Delivery Approaches
30 déc. 2020 05h23 HE | Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Viral Vector and Plasmid DNA Manufacturing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics Announces an Investment in Mass Spectrometry Services
15 juil. 2020 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, July 15, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics Promotes John Mott to Vice President of Development
13 juil. 2020 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, July 13, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the promotion of Dr. John...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics Promotes Dr. Jesse McCool to Chief Executive Officer
30 mars 2020 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, March 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the appointment of Dr. Jesse...
Aldevron Adds DasherGFP® mRNA to its Product Portfolio
12 févr. 2020 10h30 HE | Aldevron
Fargo, N.D., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies for the biotech industry, announced...